Clearmind Medicine Inc.
Expected move
InputsNext report
Last report
—
Largest filed tie
—
13F top-10 QoQ
—
Top fund weight
—
Clearmind Medicine Inc.
Expected move
InputsNext report
Last report
—
Largest filed tie
—
13F top-10 QoQ
—
Top fund weight
—
Clearmind Medicine Inc.
6.10
−0.04 · −0.65%
News
No changes.
No changes.
| Manager | Value | % base | |
|---|---|---|---|
| HRT Financial | $77,000 | 71.38% | new |
| Citadel | $25,762 | 23.88% | new |
| AdvisorShares | $2,572 | 2.38% | new |
| Morgan Stanley | $1,540 | 1.43% | new |
| Royal Bank of Canada | $1,000 | 0.93% | new |
| Manager | Value | % base | |
|---|---|---|---|
| HRT Financial | $77,000 | 71.38% | new |
| Citadel | $25,762 | 23.88% | new |
| AdvisorShares | $2,572 | 2.38% | new |
| Morgan Stanley | $1,540 | 1.43% | new |
| Royal Bank of Canada | $1,000 | 0.93% | new |
Same SIC code · 6
Same SEC industry code: ELI Lilly & Co, Johnson & Johnson, AbbVie Inc. and 3 more; no measured co-movers for Clearmind Medicine Inc..
Same SIC code · 6
Same SEC industry code: ELI Lilly & Co, Johnson & Johnson, AbbVie Inc. and 3 more; no measured co-movers for Clearmind Medicine Inc..
N/A
N/A
Annual filing, covered
20-F parsed · Jan 20 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
20-F parsed · Jan 20 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
Expected move
No implied move.
—
—